A Novel KCNQ2 Variant in a Patient with a Combined Tremor Syndrome

Giulia Paparella; Eleonora Galosi; Emanuele Cerulli Irelli; Luca Angelini; Daniele Birreci; Davide Costa; Martina De Riggi; Antonio Cannavacciuolo; Andrea Truini; Matteo Bologna

doi:10.5334/tohm.887

Abstract

Background: Tremor disorders have various genetic causes.

Case report: A 60-year-old female with a family history of tremor presented a combined tremor syndrome, transient episodes of loss of contact and speech disturbances, as well as distal painful symptoms. Genetic screening revealed a novel heterozygous missense variant in the KCNQ2 gene.

Discussion: The KCNQ2 protein regulates action potential firing, and mutations in its gene are associated with epilepsy and neuropathic pain. The identified variant, although of uncertain significance, may disrupt KCNQ2 function and also play a role in tremor pathogenesis. This case highlights the importance of genetic screening in combined tremor disorders.

References

1Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord Off J Mov Disord Soc. 2018; 33(1): 75–87. DOI: 10.1002/mds.27121
Back to article
2Magrinelli F, Latorre A, Balint B, Mackenzie M, Mulroy E, Stamelou M, et al. Isolated and combined genetic tremor syndromes: a critical appraisal based on the 2018 MDS criteria. Parkinsonism Relat Disord. agosto. 2020; 77: 121–40. DOI: 10.1016/j.parkreldis.2020.04.010
Back to article
3Hopfner F, Helmich RC. The etiology of essential tremor: Genes versus environment. Parkinsonism Relat Disord. gennaio. 2018; 46(Suppl 1): S92–6. DOI: 10.1016/j.parkreldis.2017.07.014
Back to article
4Yeow D, Rudaks LI, Siow SF, Davis RL, Kumar KR. Genetic Testing of Movements Disorders: A Review of Clinical Utility. Tremor Hyperkinetic Mov N Y N. 2024; 14(2):. DOI: 10.5334/tohm.835
Back to article
5Diez-Fairen M, Bandres-Ciga S, Houle G, Nalls MA, Girard SL, Dion PA, et al. Genome-wide estimates of heritability and genetic correlations in essential tremor. Parkinsonism Relat Disord. luglio. 2019; 64: 262–7. DOI: 10.1016/j.parkreldis.2019.05.002
Back to article
6Bologna M, Espay AJ, Fasano A, Paparella G, Hallett M, Berardelli A. Redefining Bradykinesia. Mov Disord Off J Mov Disord Soc. 27 febbraio 2023. DOI: 10.1002/mds.29362
Back to article
7Bologna M, Paparella G, Fasano A, Hallett M, Berardelli A. Evolving concepts on bradykinesia. Brain J Neurol. 1 marzo. 2020; 143(3): 727–50. DOI: 10.1093/brain/awz344
Back to article
8Paparella G, Fasano A, Hallett M, Berardelli A, Bologna M. Emerging concepts on bradykinesia in non-parkinsonian conditions. Eur J Neurol. 1 aprile 2021. DOI: 10.1111/ene.14851
Back to article
9Angelini L, Paparella G, De Biase A, Maraone A, Panfili M, Berardelli I, et al. Longitudinal study of clinical and neurophysiological features in essential tremor. Eur J Neurol. 27 novembre 2022. DOI: 10.1111/ene.15650
Back to article
10Paparella G, Cannavacciuolo A, Angelini L, Costa D, Birreci D, Alunni Fegatelli D, et al. May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals? J Park Dis. 2023; 13(6): 1049–62. DOI: 10.3233/JPD-230119
Back to article
11Bologna M, Berardelli I, Paparella G, Ferrazzano G, Angelini L, Giustini P, et al. Tremor Distribution and the Variable Clinical Presentation of Essential Tremor. Cerebellum Lond Engl. ottobre. 2019; 18(5): 866–72. DOI: 10.1007/s12311-019-01070-0
Back to article
12Paparella G, Angelini L, De Biase A, Cannavacciuolo A, Colella D, Di Bonaventura C, et al. Clinical and Kinematic Features of Valproate-Induced Tremor and Differences with Essential Tremor. Cerebellum Lond Engl. 16 novembre 2020. DOI: 10.1007/s12311-020-01216-5
Back to article
13Angelini L, Terranova R, Lazzeri G, van den Berg KRE, Dirkx MF, Paparella G. The role of laboratory investigations in the classification of tremors. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. dicembre 2023; 44(12): 4183–92. DOI: 10.1007/s10072-023-07108-w
Back to article
14Deuschl G, Becktepe JS, Dirkx M, Haubenberger D, Hassan A, Helmich RC, et al. The clinical and electrophysiological investigation of tremor. Clin Neurophysiol Off J Int Fed Clin Neurophysiol. aprile 2022; 136: 93–129. DOI: 10.1016/j.clinph.2022.01.004
Back to article
15Liu HF, Yuan TY, Yang JW, Li F, Wang F, Fu HM. A novel de novo heterozygous variant of the KCNQ2 gene: Contribution to early-onset epileptic encephalopathy in a female infant. Mol Med Rep. settembre 2022; 26(3): 282. DOI: 10.3892/mmr.2022.12797
Back to article
16Goto A, Ishii A, Shibata M, Ihara Y, Cooper EC, Hirose S. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy. Epilepsia. settembre 2019; 60(9): 1870–80. DOI: 10.1111/epi.16314
Back to article
17Al Yazidi G, Shevell MI, Srour M. Two Novel KCNQ2 Mutations in 2 Families With Benign Familial Neonatal Convulsions. Child Neurol Open. 2017;4:2329048X17691396. DOI: 10.1177/2329048X17691396
Back to article
18Schmidt A, Röner S, Mai K, Klinkhammer H, Kircher M, Ludwig KU. Predicting the pathogenicity of missense variants using features derived from AlphaFold2. Bioinforma Oxf Engl. 4 maggio 2023; 39(5): btad280. DOI: 10.1093/bioinformatics/btad280
Back to article
19Niroula A, Vihinen M. How good are pathogenicity predictors in detecting benign variants? PLoS Comput Biol. febbraio 2019; 15(2): e1006481. DOI: 10.1371/journal.pcbi.1006481
Back to article
20Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet. maggio 2015; 17(5): 405–24. DOI: 10.1038/gim.2015.30
Back to article
21Fritch PC, McNaughton-Smith G, Amato GS, Burns JF, Eargle CW, Roeloffs R, et al. Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain. J Med Chem. 28 gennaio 2010; 53(2): 887–96. DOI: 10.1021/jm901497b
Back to article
22Ślęczkowska M, Misra K, Santoro S, Gerrits MM, Hoeijmakers JGJ, PainNet Study Group. Ion Channel Genes in Painful Neuropathies. Biomedicines. 29 settembre 2023; 11(10): 2680. DOI: 10.3390/biomedicines11102680
Back to article
23Bennett DLH, Woods CG. Painful and painless channelopathies. Lancet Neurol. giugno 2014; 13(6): 587–99. DOI: 10.1016/S1474-4422(14)70024-9
Back to article
24d’Apolito M, Ceccarini C, Savino R, Adipietro I, di Bari I, Santacroce R, et al. A Novel KCNN2 Variant in a Family with Essential Tremor Plus: Clinical Characteristics and In Silico Analysis. Genes. 29 giugno 2023; 14(7): 1380. DOI: 10.3390/genes14071380
Back to article

A Novel KCNQ2 Variant in a Patient with a Combined Tremor Syndrome

Abstract

Paradigm

My account